Saturday November 21 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Malignant Carcinoid Syndrome

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Malignant Carcinoid Syndrome:

Pubmed Logo
Case of carcinoid crisis following a fine-needle biopsy of hepatic metastasis.
Fine-needle biopsy of hepatic lesions in a patient with carcinoid liver...
10th September, 2009
Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, Eur J Gastroenterol Hepatol. 2009 Jan;21(1):101-3.
Carcinoid syndrome.
BACKGROUND: Octreotide LAR is an established treatment for malignant...
23rd July, 2009
Department of Internal Medicine, Regina General Hospital, Regina CMAJ. 2009 Jun 23;180(13):1329.
DOI Direct Link
Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR.
BACKGROUND: Octreotide LAR is an established treatment for malignant...
4th July, 2009
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK. Aliment Pharmacol Ther. 2009 Oct;30(7):733-40. Epub 2009 Jul 2.
DOI Direct Link
[Rectal carcinoids on the rise - update]
Rectal carcinoids are becoming more common: in the USA they have increased...
27th June, 2009
Klinik fur Innere Medizin - Gastroenterologie und GI Onkologie, Z Gastroenterol. 2009 Apr;47(4):365-71. Epub 2009 Apr 8.
DOI Direct Link
Development and characterization of a novel in vivo model of carcinoid syndrome.
PURPOSE: Carcinoid syndrome, characterized by flushing, diarrhea, and...
6th June, 2009
Department of Surgery and Pathology, The University of Texas Medical Clin Cancer Res. 2009 Apr 15;15(8):2747-55. Epub 2009 Mar 31.
DOI Direct Link

View more research publications.

Press Releases About Malignant Carcinoid Syndrome:

BioPortfolio Logo
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) 20th November, 2009 Merck & Co., Inc.
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has
Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 18th November, 2009 Viron Therapeutics Inc.
VT-111 significantly reduces key cardiac enzymes at multiple time points after stent placement; Data presented at American Heart Association 2009 Scientific Sessions LONDON, ON, Nov. 18 /PRNewswire/
Oklahoma Medical Research Foundation Accelerates Discovery With Isilon IQ 18th November, 2009 Isilon Systems
SEATTLE, Nov. 18 /PRNewswire-FirstCall/ -- IsilonĀ® Systems (Nasdaq: ISLN) today announced that the Oklahoma Medical Research Foundation (OMRF), a nonprofit biomedical research institute, has
Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation 18th November, 2009 Albireo
GOTHENBURG, Sweden, November 18 /PRNewswire/ -- Albireo today announced the completion of a phase 1b study showing a favorable tolerability and safety profile of A3309 in patients with chronic
Albireo Announces Positive Clinical Data on A3309 in Patients with Chronic Idiopathic Constipation 18th November, 2009
GOTHENBURG, Sweden, November 18 /PRNewswire/ -- Albireo today announced the completion of a phase 1b study showing a favourable tolerability and safety profile of A3309 in patients with chronic

Malignant Carcinoid Syndrome Clinical Trials:

Clinical Trials Logo
Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

Malignant Carcinoid Syndrome Patents:

USPTO Logo
US Patent No.Title
5804380 Telomerase activity assays
6365362 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
6368789 Screening methods to identify inhibitors of telomerase activity
6391554 Detecting cancerous conditions by assaying for telomerase activity
6475789 Human telomerase catalytic subunit: diagnostic and therapeutic methods

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Malignant Carcinoid Syndrome scientists - we have details of around 156 individuals working on Malignant Carcinoid Syndrome .


This page has been viewed 408 times
Recent Search Terms used to find this page: carcinoid maligance | updates in carcinoid syndrome 2009 | Nephrology and carcinoid | malignant carcinoid syndrome | Comparison of Lanreotide Autogel and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome | prognosis carcinoid syndroom | malignant carcinoid syndrome | sandostatin and carcinoid and case study | maligant carcinoid | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Malignant Carcinoid Syndrome across BioPortfolio, or for Malignant Carcinoid Syndrome Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.